You’re offline. This is a read only version of the page.
Skip to main content
Toggle navigation
Products
Therapeutic Guidelines
Australian Prescriber
Australian Injectable Handbook
ObesiD
Don't Rush to Crush
RPHCMs
What We Do
Guidelines Development
Expert Groups
Research Funding
Governance
About Us
Our People
Join The Team
Our History
Resource Hub
FAQs
Contact Us
News
Login
Subscribe
DRTC Updates
Don't Rush to Crush
Therapeutic Guidelines
Overview
Updates
Books
Antibiotic Summary
AIDH
Overview
Updates
ObesiD
Don't Rush to Crush
Overview
Updates
Australian Prescriber
RPHCMs
New content updates
Our next update to Don't Rush to Crush will be available in September.
Subscribe to updates
Subscribe to receive news and product updates.
Subscribe
What's new in Don't Rush to Crush
The Australian Don't Rush to Crush Handbook is a comprehensive reference of over 600 oral medicines currently available in Australia.
Monographs in Don't Rush to Crush are now reviewed and updated in therapeutic groups. Details about each update can be found below by release date.
March 2026
New monographs (2)
dapagliflozin and metformin
flucytosine
Monograph updates (114)
antimicrobials
diabetes
Monographs with significant changes (5)
Biktarvy (new dispersion data)
cabotegravir (crushing advice removed)
cefuroxime (additional liquid formulation available)
pyrazinamide (dispersion data removed)
sulfadiazine (dispersion data removed)
Deleted monographs (15)
baloxavir
cobicistat
efavirenz
emtricitabine
ertuglifozin
Eviplera
fosamprenavir
Harvoni
ribavirin
saquinavir
sofosbuvir
Stribild
tripranavir
Trizivir
Zepatier